Cardiovascular effects of covid-19 – what do we know and where should we go?

Matthew Ryan, Ozan Demir, Kevin O’gallagher, Divaka Perera*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Abstract

Amongst the many challenges of the global pandemic, understanding the effects of coronavirus disease 2019 (COVID-19) on the cardiovascular system has emerged as a key priority. Emerging data indicate possible roles for cardiac biomarkers and cardiac imaging in the prognostic assessment of these patients, as well as implications of the vascular endothelium in the pathogenesis of the condition. From a therapeutic perspective, early data suggest that the provision of well-established treatments for cardiovascular disease, whether with angiotensin-converting enzyme inhibitors or primary angioplasty, is likely to be beneficial. These early data are of limited quality however, and robust studies are needed to address many of the key remaining questions.

Original languageEnglish
Pages (from-to)16-19
Number of pages4
JournalHeart International
Volume14
Issue number1
DOIs
Publication statusPublished - 2020

Keywords

  • Cardiovascular disease
  • Coronavirus disease 2019
  • COVID-19
  • Myocarditis
  • SARS-CoV2

Fingerprint

Dive into the research topics of 'Cardiovascular effects of covid-19 – what do we know and where should we go?'. Together they form a unique fingerprint.

Cite this